SCHEMBL5147109

SCHEMBL5147109

NC(=O)c1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.51
ALDH1A1 P00352 4/20 0.51
PKM P14618 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 9/20 0.49
HTT P42858 3/20 0.49
LMNA P02545 2/20 0.49
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NOD1 Q9Y239 1/20 0.45
POLB P06746 2/20 0.45
CTPS1 P17812 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
PARP1 P09874 1/20 0.41
GALR3 O60755 1/20 0.41
TP53 P04637 1/20 0.40
APAF1 O14727 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147102 0.83 HDAC1 (0.48) ALDH1A1NPC1SMN1; SMN2HDAC1HDAC6
SCHEMBL5147126 0.83 HDAC1 (0.46) MAPTNPC1MEN1KMT2AHDAC1
SCHEMBL5147078 0.83 HDAC1 (0.48) MAPTLMNANPC1MEN1KMT2A
SCHEMBL5145477 0.83 HDAC1 (0.46) ALDH1A1NPC1SMN1; SMN2HDAC1HDAC6
SCHEMBL5147069 0.80 HDAC1 (0.44) GAAALDH1A1PKMMAPTHTT
SCHEMBL5147172 0.80 HDAC1 (0.44) NPC1MEN1KMT2AHDAC1HDAC6
SCHEMBL5147042 0.78 HDAC1 (0.44) NPC1MEN1KMT2AHDAC1HDAC6
SCHEMBL5147159 0.75 HDAC1 (0.45) GAAALDH1A1MAPTNPC1MEN1
SCHEMBL14422435 0.75 HDAC1 (0.43) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL4762936 0.75 ALDH1A1 (0.45) GAAALDH1A1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 GAA 3711/4885ALDH1A1 2098/4885PKM 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.